Surface plasmon resonance is a technique which is used to analyze kinetics of interaction between biomolecules. This is an emerging technique for label-free detection in real time for bio molecular interactions. Surface plasmon resonance technique offers benefits such as high specificity and sensitivity and is based on the principle of total internal reflection and is mainly used in pharmaceutical and biotechnology companies, food industry and clinical research organization. This technique is used in various fields such as drug discovery, material science and biosensors. SPR technique also used for various purposes such as to identifying binding specificity of two or more molecules, determining affinity of the reaction, and measuring association and dissociation rate. In terms of value, the global surface plasmon resonance market is anticipated to be valued at US$ 1273.8 Mn by 2027, exhibiting a 6.3% CAGR during the forecast period.
The global surface plasmon resonance market is mainly driven by increasing adoption of label-free detection techniques over labelled detection techniques due to cost-effectiveness, availability of versatile products in the SPR market for refined outcomes and coupling of complementary techniques with SPR to enhance specificity of the test are major factors leading to increased demand for surface plasmon resonance. This in turn is fuelling growth of the global surface plasmon resonance market. Emergence of alternative techniques for detection of protein and high prices of products are few factors expected to hamper growth of the global surface plasmon resonance market to a certain extent. Major trends in the surface plasmon resonance market include increased adoption of microfluidics technique to lower consumption of reagent, introduction of advanced imaging software for analysis of surface plasmon resonance and consistent investment in research and development by various companies.
Development of SPR based point of care devices presents a huge opportunity in the market
Application of SPR for the development of point-of-care devices has been a primary area of focus in the recent past. Companies are focused on developing of point-of-care devices based on SPR technique; however, factors such as mass fabrication of durable metal nanostructure on the substrate, detection sensitivity shortage and high cost incurred for the combination of microfluidic chip with the POC system and the sensor is hampering development of POC devices. Researchers are continuously working on taking SPR technique out of the laboratories and to sites closer to the common user through development of user-friendly device. However, the current SPR technique does not pose any significant competition to costly POC devices using labelled detection techniques.
By region, the global surface plasmon resonance market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa (MEA). Globally, in terms of revenue, North America has been estimated to account for the highest share of 35.5% in 2017, followed by Western Europe. Meanwhile, revenue from the market in Asia Pacific excluding Japan (APEJ) is expected to expand at the significant CAGR of 7.4% over the forecast period. The North America surface plasmon resonance market was estimated to be valued at nearly US$ 250 Mn in 2017 and is forecasted to reach a valuation of nearly US$ 470 Mn in 2017, exhibiting a CAGR of 6.7% during the period of assessment from 2017-2027. The Latin America surface plasmon resonance market was estimated to be valued at nearly US$ 50 Mn in 2017, and is anticipated to reach a valuation of nearly US$ 70 Mn in 2027, exhibiting a CAGR of 4.6% during the period of forecast.
Our reports have been used by over 10K customers, including:
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
168 pages •
By Global Industry Analysts
• Apr 2021
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
Transcriptomics Technologies Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Transcriptomics Technologies market including the COVID-19 pandemic...
23andMe, Inc - Tech Innovator Profile
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
The report provides information and insights into 23andMe, Inc.’s, including...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.